AGP Executive Report
Last update: 6 hours agoObesity Research: Roche will pay up to $1.16 billion for rights to a Chinese biotech’s experimental RNAi drug, targeting a pathway that may reduce fat while preserving muscle. Swiss Science: University of Geneva researchers found that switching to an all-plant-protein diet quickly changed liver metabolism in mice and reduced their willingness to exercise. Quantum Technology: Infineon and Swiss startup ZuriQ are expanding work on scalable trapped-ion quantum chips. Cybersecurity: Geneva-based SEALSQ presented research showing how side-channel leakage could expose secrets during ML-KEM key generation, highlighting security challenges for post-quantum cryptography. Virology: The Geneva Centre for Emerging Viral Diseases has joined the Global Virus Network, adding Swiss expertise in emerging infections, vaccines and surveillance to its international network.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.